Lateral flow diagnostic tests, which are also known as lateral flow immunology assays, are carried out to detect the presence of a target analyte in human body fluid samples. These medical diagnostic tests are suitable for point of care testing, home testing, and laboratory use.
In the APAC region, the increasing incidence of infectious diseases has been the reason for the rising need for increasing the ease of access of medical diagnostics. For such needs, lateral flow tests are suitable for their ease of use and minimal dependence on the operator for carrying out the test and interpreting the results.
The changing lifestyle of the population of the APAC region, where individuals are shifting preference towards self-care and home diagnostics, is augmenting the demand for lateral flow diagnostic tests for home testing. In addition, several governments in the region are supporting point of care and home testing to lessen the burden on state-led healthcare programs, which in turn is benefitting the APAC lateral flow diagnostic tests market.
In the APAC region, the increasing incidence of infectious diseases has been the reason for the rising need for increasing the ease of access of medical diagnostics. For such needs, lateral flow tests are suitable for their ease of use and minimal dependence on the operator for carrying out the test and interpreting the results.
The changing lifestyle of the population of the APAC region, where individuals are shifting preference towards self-care and home diagnostics, is augmenting the demand for lateral flow diagnostic tests for home testing. In addition, several governments in the region are supporting point of care and home testing to lessen the burden on state-led healthcare programs, which in turn is benefitting the APAC lateral flow diagnostic tests market.
Application of Lateral Flow Diagnostics Rising in Hepatitis Testing
The APAC lateral flow diagnostic tests market is divided on the basis of application and region. By application, pregnancy, HIV, syphilis, hepatitis, influenza, malaria, and others (cardiac markers, lung disorders, drug abuse, etc.) are the segments of the lateral flow diagnostic tests market. Amongst all, it is the pregnancy application segment that dominated the market and held 26.4% of the overall market in 2014. Increasing birth rate and ease of use of test kits are the key reasons for the large share of the pregnancy application segment.
However, it is the hepatitis application segment that will exhibit the highest growth rate in the foreseeable years. The increasing prevalence of immunological diseases has been favorable for alternative testing such as point of care and home testing that employ lateral flow diagnostic methodologies. In addition, the ease of use of lateral flow diagnostic test kits, which demands minimal education for both users and regulators, will be favorable for the growth of the hepatitis application segment of the market. The use of lateral flow diagnostics also facilitates easy handling of multiple types of samples that are present in small volumes for hepatitis testing.
The APAC lateral flow diagnostic tests market is divided on the basis of application and region. By application, pregnancy, HIV, syphilis, hepatitis, influenza, malaria, and others (cardiac markers, lung disorders, drug abuse, etc.) are the segments of the lateral flow diagnostic tests market. Amongst all, it is the pregnancy application segment that dominated the market and held 26.4% of the overall market in 2014. Increasing birth rate and ease of use of test kits are the key reasons for the large share of the pregnancy application segment.
However, it is the hepatitis application segment that will exhibit the highest growth rate in the foreseeable years. The increasing prevalence of immunological diseases has been favorable for alternative testing such as point of care and home testing that employ lateral flow diagnostic methodologies. In addition, the ease of use of lateral flow diagnostic test kits, which demands minimal education for both users and regulators, will be favorable for the growth of the hepatitis application segment of the market. The use of lateral flow diagnostics also facilitates easy handling of multiple types of samples that are present in small volumes for hepatitis testing.
Improving Healthcare System Favorable for Indonesia Lateral Flow Diagnostic Tests Market
Among the regional segments, in 2014, Japan dominated the lateral flow diagnostic tests market in APAC, accounting for 22.05% of the overall market. This is mainly due to consistent advancements in the design and technology of the apparatus and launch of government initiatives to spread awareness about infectious diseases and their remedies. In Japan, the increasing birth rate and rising incidence of life-threatening diseases are the other factors supporting the growth of the lateral flow diagnostic tests market.
Indonesia will be the most lucrative market for lateral flow diagnostic tests and will exhibit the highest growth rate of 9.20% from 2015 to 2023. In Indonesia, increasing population, rising health awareness, and an improved healthcare system are the reasons for the high growth rate of the regional segment.
Some major companies that operate in the APAC lateral flow diagnostic tests market are Alere Inc., Becton, bioMérieux SA, EMD Millipore, Siemens Healthcare, Beckham Coulter Inc., Dickinson and Company, Bio-Rad Laboratories, Hoffmann-La Roche Ltd., and QIAGEN.
Browse Full APAC Lateral Flow Diagnostic Tests Market Report With Complete TOC @ http://www.transparencymarketresearch.com/apac-lateral-flow-diagnostic-tests-market.html
Among the regional segments, in 2014, Japan dominated the lateral flow diagnostic tests market in APAC, accounting for 22.05% of the overall market. This is mainly due to consistent advancements in the design and technology of the apparatus and launch of government initiatives to spread awareness about infectious diseases and their remedies. In Japan, the increasing birth rate and rising incidence of life-threatening diseases are the other factors supporting the growth of the lateral flow diagnostic tests market.
Indonesia will be the most lucrative market for lateral flow diagnostic tests and will exhibit the highest growth rate of 9.20% from 2015 to 2023. In Indonesia, increasing population, rising health awareness, and an improved healthcare system are the reasons for the high growth rate of the regional segment.
Some major companies that operate in the APAC lateral flow diagnostic tests market are Alere Inc., Becton, bioMérieux SA, EMD Millipore, Siemens Healthcare, Beckham Coulter Inc., Dickinson and Company, Bio-Rad Laboratories, Hoffmann-La Roche Ltd., and QIAGEN.
Browse Full APAC Lateral Flow Diagnostic Tests Market Report With Complete TOC @ http://www.transparencymarketresearch.com/apac-lateral-flow-diagnostic-tests-market.html
No comments:
Post a Comment